Podcast conversation on rapamycin, mTOR and longevity research
In this podcast description, Matt Kaeberlein discusses how mTOR research shaped views of aging, why rapamycin is debated, and what human trials can and cannot show so far. [1]
Automatic summary · not editorially reviewed
The key findings
The description says research on mTOR helped shape understanding of aging and that rapamycin remains one of the most debated interventions in the field. [1]
According to the description, Matt discusses what human trials can and cannot tell us so far. [1]
The description lists the Dog Aging Project and TRIAD trial, companion animal longevity, and AI-powered lifespan research as further topics. [1]
The source at a glance
- Study type / format
- Video description of a podcast episode
- Population / context
- Podcast conversation with Professor Matt Kaeberlein, hosted by Dr. Raghav Sehgal and Dr. Macsue Jacques
- Summary based on
- Creator description
- Original publication
- September 16, 2026
mTOR research and the debate around rapamycin
The description says the conversation covers aging biology, rapamycin and the future of longevity science. According to the description, Matt explains how research on mTOR helped shape understanding of aging and why rapamycin remains one of the most debated interventions in the field. The description does not report specific study results, doses or effects on human lifespan.
Supporting source [1]
What human trials can and cannot show so far
The description states that Matt discusses what human trials can and cannot tell us so far. It gives no trial names, participant numbers, outcomes or results for this part of the conversation. The description therefore supports only that this topic was discussed, not any conclusion about benefit or harm in people.
Supporting source [1]
Dog Aging Project, TRIAD and AI lifespan research
Beyond rapamycin, the description lists Aura Biomedical and AI-powered lifespan research, the Dog Aging Project and the TRIAD trial, companion animal longevity, and the role of science in longevity biotech and investment. No findings from these projects are reported in the description. The hosts are Dr. Raghav Sehgal and Dr. Macsue Jacques; the guest is Professor Matt Kaeberlein.
Supporting source [1]
How to interpret this
Only the video description was available; the video and transcript were not reviewed. The description names topics but reports no study designs, sample sizes, outcomes or results, so no effect on human aging can be inferred.
Based on the creator’s description; the full video and transcript were not analyzed.
Source & supporting passages
Decoding Longevity · youtube.com · September 16, 2026